Homology modeling and SAR analysis of Schistosoma japonicum cathepsin D (SjCD) with statin inhibitors identify a unique active site steric barrier with potential for the design of specific inhibitors

Abstract Proteases that digest the blood-meal of the parasitic fluke Schistosoma are potential targets for therapy of schistosomiasis, a disease of chronic morbidity in humans. We generated a three-dimensional model of the cathepsin D target protease of Schistosoma japonicum (SjCD) utilizing the crystal structure of human cathepsin D (huCD) in complex with pepstatin as template. A homology model was also generated for the related secreted aspartic protease 2 (SAP2) of the pathogenic yeast, Candida albicans. An initial panel of seven statin inhibitors, originally designed for huCD [Majer et al., Protein Sci. 6 (1997), pp. 1458–1466], was tested against the two pathogen proteases. One inhibitor showed poor reactivity with SjCD. Examination of the SjCD active-site cleft revealed that the poor inhibition was due to a unique steric barrier situated between the S2 and S4 subsites. An in silico screen of 20 potential statin scaffolds with the SjCD model and incorporating the steric barrier constraint was performed. Four inhibitors (SJ1–SJ4) were eventually synthesized and tested with SjCD, bovine CD and SAP2. Of these, SJ2 and SJ3 proved moderately more specific for SjCD over bovine CD, with IC50 values of 15 and 60 nM, respectively. The unique steric barrier identified here provides a structural focus for further development of more specific SjCD inhibitors.

[1]  Feng Liu,et al.  Evolutionary and biomedical implications of a Schistosoma japonicum complementary DNA resource , 2003, Nature Genetics.

[2]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[3]  D. Veber,et al.  HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. , 1988, Biochemical and biophysical research communications.

[4]  C. Morris,et al.  Identification and characterisation of an aspartyl protease inhibitor homologue as a major allergen of Trichostrongylus colubriformis. , 2003, International journal for parasitology.

[5]  M Hendlich,et al.  Databases for protein-ligand complexes. , 1998, Acta crystallographica. Section D, Biological crystallography.

[6]  K. Fujikawa,et al.  Aspartic protease inhibitors from the parasitic nematode Ascaris. , 1991, Advances in Experimental Medicine and Biology.

[7]  R E Cachau,et al.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Collins,et al.  Structure‐based subsite specificity mapping of human cathepsin D using statine‐based inhibitors , 1997, Protein science : a publication of the Protein Society.

[9]  I. Pichová,et al.  Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. , 2001, European journal of biochemistry.

[10]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[11]  C. Abad-Zapatero,et al.  Candida proteases and their inhibition: prospects for antifungal therapy. , 2001, Current medicinal chemistry.

[12]  Edward J. Pearce,et al.  The immunobiology of schistosomiasis , 2002, Nature Reviews Immunology.

[13]  M. Sajid,et al.  Blood 'n' guts: an update on schistosome digestive peptidases. , 2004, Trends in parasitology.

[14]  Robert D Clark,et al.  Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. , 1996, Journal of medicinal chemistry.

[15]  L. Schmidt,et al.  Structural basis of oncogenic activation caused by point mutations in the kinase domain of the MET proto‐oncogene: Modeling studies , 2001, Proteins.

[16]  B. Anderson,et al.  The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. , 1995, Structure.

[17]  L. Chitsulo,et al.  Focus: Schistosomiasis , 2004, Nature Reviews Microbiology.

[18]  J. Dalton,et al.  Cloning and Characterization of the Schistosoma japonicum Aspartic Proteinase Involved in Hemoglobin Degradation (*) , 1995, The Journal of Biological Chemistry.

[19]  C. Caffrey,et al.  Schistosoma japonicum and S. mansoni: effect of cyclosporin A on aspartic and cysteine hemoglobinolytic activities , 1998 .

[20]  V. Tomášek,et al.  Isolation and some properties of cathepsin D inhibitor from potatoes , 1976 .

[21]  A. Loukas,et al.  Hookworm aspartic protease, Na-APR-2, cleaves human hemoglobin and serum proteins in a host-specific fashion. , 2003, The Journal of infectious diseases.

[22]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[23]  D. Nisato,et al.  Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid , 1987 .

[24]  T. Halgren,et al.  A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site. , 1995, Journal of medicinal chemistry.

[25]  D. Fairlie,et al.  Proteolysis of human hemoglobin by schistosome cathepsin D. , 2001, Molecular and biochemical parasitology.

[26]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[27]  J. McKerrow,et al.  Cysteine protease inhibitors block schistosome hemoglobin degradation in vitro and decrease worm burden and egg production in vivo. , 1996, Molecular and biochemical parasitology.

[28]  S. Giovanni-De-Simone,et al.  Exploring the subsite specificity of Schistosoma mansoni aspartyl hemoglobinase through comparative molecular modelling , 2002, FEBS letters.

[29]  A. Ruppel,et al.  Schistosoma mansoni and S. japonicum: comparison of levels of ultraviolet irradiation for vaccination of mice with cercariae , 1990, Parasitology.

[30]  A. Loukas,et al.  Hemoglobin-degrading, Aspartic Proteases of Blood-feeding Parasites , 2001, The Journal of Biological Chemistry.

[31]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[32]  V. Kulkarni,et al.  Insights into the selective inhibition of Candida albicans secreted aspartyl protease: a docking analysis study. , 2002, Bioorganic & medicinal chemistry.

[33]  A Wlodawer,et al.  Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. , 1998, Annual review of biophysics and biomolecular structure.